...and Opko Health Inc. (NASDAQ:OPK) said once-weekly somatrogon met its primary endpoint vs. once-daily Genotropin somatropin...

...BLA for TransCon hGH lonapegsomatropin to treat pediatric growth hormone deficiency. The long-acting prodrug of somatropin...

...pathway. These include naturally sourced products such as hyaluronidase and recombinant proteins such as Omnitrope somatropin...

...trading Thursday after reporting that somavaratan (VRS-317) missed the primary endpoint of non-inferiority to Genotropin somatropin...

...Versartis Inc. (NASDAQ:VSAR) said somavaratan (VRS-317) missed the primary endpoint of non-inferiority to Genotropin somatropin in...

...NYSE:NVO) Growth hormone deficiency Marketed Genotropin somatropin Pfizer Inc. (NYSE:PFE) Growth hormone deficiency Marketed Omnitrope somatropin...

...an open-label, U.S. Phase III trial to evaluate once-weekly subcutaneous hGH-CTP vs. once-daily subcutaneous Genotropin somatropin...

...antibiotic in Factive gemifloxacin, and the first Korean company with a globally approved biologic, Valtropin somatropin...

...IGF-1 ) levels by 101.3 ng/mL vs. 109.1 ng/mL for once-daily 6 ug/kg Genotropin somatropin...

...with growth hormone deficiency showed that subcutaneous GX-H9 was well tolerated. Patients received once-daily Genotropin somatropin...